Extract from the Register of European Patents

EP About this file: EP2270030

EP2270030 - Heterologous expression of Neisserial proteins [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.03.2013
Database last updated on 09.04.2026
Most recent event   Tooltip29.03.2013No opposition filed within time limitpublished on 01.05.2013  [2013/18]
Applicant(s)For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena (SI) / IT
[2011/01]
Inventor(s)01 / Arico, Maria B.
Novartis Vaccines
Via Fiorentina 1
53100 Siena / IT
02 / Comanducci, Maurizio
Novartis Vaccines
Via Fiorentina 1
53100 Siena / IT
03 / Galeotti, Cesira
Novartis Vaccines
Via Fiorentina 1
53100 Siena / IT
04 / Masignani, Vega
Novartis Vaccines
Via Fiorentina 1
53100 Siena / IT
05 / Giuliani, Marzia Monica
Novartis Vaccines
Via Fiorentina 1
53100 Siena / IT
06 / Pizza, Mariagrazia
Novartis Vaccines
Via Fiorentina 1
53100 Siena / IT
 [2012/21]
Former [2011/01]01 / Arico, Maria B.
Novartis Vaccines Via Fiorentina 1
53100 Siena / IT
02 / Comanducci, Maurizio
Novartis Vaccines Via Fiorentina 1
53100 Siena / IT
03 / Galeotti, Cesira
Novartis Vaccines Via Fiorentina 1
53100 Siena / IT
04 / Masignani, Vega
Novartis Vaccines Via Fiorentina 1
53100 Siena / IT
05 / Giuliani, Marzia Monica
Novartis Vaccines Via Fiorentina 1
53100 Siena / IT
06 / Pizza, Mariagrazia
Novartis Vaccines Via Fiorentina 1
53100 Siena / IT
Representative(s)Marshall, Cameron John
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2012/21]Marshall, Cameron John
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Former [2011/01]Marshall, Cameron John
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Application number, filing date10178586.328.02.2001
[2011/01]
Priority number, dateGB2000000469528.02.2000         Original published format: GB 0004695
GB2000002767513.11.2000         Original published format: GB 0027675
[2011/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2270030
Date:05.01.2011
Language:EN
[2011/01]
Type: A3 Search report 
No.:EP2270030
Date:02.02.2011
[2011/05]
Type: B1 Patent specification 
No.:EP2270030
Date:23.05.2012
Language:EN
[2012/21]
Search report(s)(Supplementary) European search report - dispatched on:EP05.01.2011
ClassificationIPC:C07K14/22, C07K19/00, C12N15/31, A61K39/095
[2011/01]
CPC:
C12Q1/689 (EP,US); A61K39/095 (US); A61P31/04 (EP);
A61P37/04 (EP); C07K14/22 (EP,US); C12P21/00 (US);
C12P21/02 (US); A61K2039/545 (US); A61K2039/55505 (US);
A61K2039/572 (US); A61K2039/575 (US); A61K38/00 (EP,US);
C07K2319/00 (EP,US); C12Q2600/156 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2011/01]
TitleGerman:Heterologe Expression Neisserscher Proteine[2011/01]
English:Heterologous expression of Neisserial proteins[2011/01]
French:Expression hétérologue de protéines de Neisserial[2011/01]
Examination procedure02.08.2011Amendment by applicant (claims and/or description)
02.08.2011Examination requested  [2011/42]
24.11.2011Communication of intention to grant the patent
26.03.2012Fee for grant paid
26.03.2012Fee for publishing/printing paid
Parent application(s)   TooltipEP01914109.2  / EP1259627
EP06076718.3  / EP1790660
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010914109) is  27.04.2004
Opposition(s)26.02.2013No opposition filed within time limit [2013/18]
Fees paidRenewal fee
23.09.2010Renewal fee patent year 03
23.09.2010Renewal fee patent year 04
23.09.2010Renewal fee patent year 05
23.09.2010Renewal fee patent year 06
23.09.2010Renewal fee patent year 07
23.09.2010Renewal fee patent year 08
23.09.2010Renewal fee patent year 09
23.09.2010Renewal fee patent year 10
15.02.2011Renewal fee patent year 11
15.02.2012Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A] WO9957280  (CHIRON CORP et al.)
by applicantWO9924578
 WO9936544
 WO9957280
 WO0022430
 WO0066741
   EVANS, INFECT.IMMUN., vol. 10, 1974, pages 1010 - 1017
   FILIP, J.BACT., vol. 115, 1973, pages 717 - 722
   DAVIES, J.IMMUNOL.METH., vol. 143, 1990, pages 215 - 225
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.